OpenVSafe by OpenVAERS
Search V-safe

F3Y-97293-66158

3 vaccinations 8 coded responses 32 check-ins 8 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
775 / TX
Registered
2021-01-28
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-28
    Registered in v-safe
  2. 2021-01-28
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-28
    Survey response — day 0, dose 1
    MedDRA: Muscle spasms — Feeling: Good · Site: Pain · Chills, Muscle or body aches
    Free text: The arm where injection was given is very crampy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site swelling, Pain in extremity — Feeling: Good · Site: Pain, Swelling
    Free text: Pain in Rt arm. Knot at injection site. Rt arm is crampy feeling. Applied Tens Unit today.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-31
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site nodule — Feeling: Good · Site: Pain, Swelling
    Free text: Quarter size knot at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Swelling · None
    Adult check-in
  8. 2021-02-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-04
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-11
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-18
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-18
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-01
    Survey response — day 42, dose 2
    MedDRA: Ageusia, Alopecia, Anosmia, Dysgeusia — Feeling: Good
    Free text: Hair loss, no sense of smell & taste is off.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-21
    Dose 3 — Pfizer-BioNTech
  28. 2021-09-30
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-10-05
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-10-12
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-10-19
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-10-26
    Survey response — day 35, dose 3
    MedDRA: Ageusia, Anosmia, Vision blurred, Vitreous floaters — Feeling: Good
    Free text: Still no taste or smell Blurred vision & floaters
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-11-02
    Survey response — day 42, dose 3
    MedDRA: Alopecia, Vision blurred, Vitreous floaters — Feeling: Good
    Free text: Hair loss, blurred vision & floaters
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-12-21
    Survey response — 3 months, dose 3
    MedDRA: Decreased appetite, Hypogeusia, Hyposmia, Vision blurred, Vitreous floaters — Feeling: Good
    Free text: Blurred vision, eye floaters, continued decreased appatite, decreased taste & smell.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-03-22
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-09-21
    Survey response — 12 months, dose 3
    MedDRA: Cataract — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cataract formation
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-09-21
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  38. 2022-09-22
  39. 2022-09-23
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-01-28Pfizer-BioNTech
22021-02-18Pfizer-BioNTech
32021-09-21Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 2 — day 0, dose 1

2021-01-28

Systemic reaction (other): The arm where injection was given is very crampy

Release 3 — days 1–6 daily, dose 1

2021-01-30

Systemic reaction (other): Pain in Rt arm. Knot at injection site. Rt arm is crampy feeling. Applied Tens Unit today.

2021-01-31

Systemic reaction (other): Quarter size knot at injection site

Release 6 — day 42, dose 2

2021-04-01

Symptoms: Hair loss, no sense of smell & taste is off.

Release 10 — day 35, dose 3

2021-10-26

Symptoms: Still no taste or smell Blurred vision & floaters

Release 10 — day 42, dose 3

2021-11-02

Symptoms: Hair loss, blurred vision & floaters

Release 10 — 3 months, dose 3

2021-12-21

Symptoms: Blurred vision, eye floaters, continued decreased appatite, decreased taste & smell.

Release 12 — 12 months, dose 3

2022-09-21

Symptoms: Cataract formation

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia ✓ ✓ ✓
SDAlopecia ✓ ✓ ✓
SDAnosmia ✓ ✓ ✓
SDCataract · · ✓
SDDecreased appetite · · ✓
SDDysgeusia · · ✓
SDHypogeusia · · ✓
SDHyposmia · · ✓
SDVision blurred · · ✓
SDVitreous floaters · · ✓
SROInjection site nodule ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SROMuscle spasms ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release